University of Pittsburgh Cancer Institute (UPCI)

Overview

The UPCI Protocol Review and Monitoring System (PRMS) comprises several specialized oversight groups. The Protocol Review Committee (PRC) of UPCI is responsible for reviewing all clinical cancer research studies conducted at the University of Pittsburgh and UPMC prior to their initiation. PRC works closely with the UPCI Data Safety and Monitoring Committee (DMSC), which is responsible for monitoring UPCI clinical research for safety, validity of data, and appropriate closure of trials. PRC has three committees: Committees A and B focus on the review of cancer treatment protocols, while Committee C is responsible for reviewing all behavioral and cancer epidemiology, cancer prevention and control, and complementary medicine protocols. The PRC evaluates each protocol to ensure appropriate study design and scientific quality, availability of outside and/or institutional resources allocated, fiscal accounting of the utilization of resources, insurance billing, and third party coverage issues.

For more information about the PRC, click here.

For more information about the DSMC, click here .